NEW YORK (GenomeWeb News) – Through the first six months of 2012, the number of mergers and acquisitions in the 'omics-related tools and molecular diagnostics markets fell nearly 30 percent compared to a year ago, though a few big deals focused on diagnostics were consummated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.